Who Owns Arcturus Therapeutics Stock?
NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 76.78%
- Held by insiders
- 9.57%
- Institutional holders
- 207
- Institutions 76.8%
- Insiders 9.6%
- Public and other 13.7%
Who owns Arcturus Therapeutics stock?
Institutional investors own about 76.8% of Arcturus Therapeutics's shares, spread across 207 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 9.57% of ARCT.
The largest institutional holders are ARK Investment Management, LLC (10.39%), Blackrock Inc. (9.35%) and Sumitomo Mitsui Trust Group, Inc. (5.86%). Together, the top 10 institutions control 52.5% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ARCT positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ARCT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| ARK Investment Management, LLC | 2.99M | 10.39% | +3.2% |
| Blackrock Inc. | 2.69M | 9.35% | +3.1% |
| Sumitomo Mitsui Trust Group, Inc. | 1.69M | 5.86% | -14.0% |
| Amova Asset Management Americas Inc | 1.69M | 5.86% | -13.8% |
| Federated Hermes, Inc. | 1.68M | 5.82% | -49.2% |
| Vanguard Capital Management LLC | 1.11M | 3.84% | -0.7% |
| Two Sigma Investments, LP | 1.09M | 3.79% | +0.9% |
| Vanguard Portfolio Management LLC | 861.24K | 2.99% | -9.5% |
| AQR Capital Management, LLC | 675.01K | 2.34% | +318.5% |
| Jacobs Levy Equity Management, Inc. | 647.51K | 2.25% | +225.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ARCT
| Fund | Shares | % Held |
|---|---|---|
| ARK ETF Trust-ARK Genomic Revolution ETF | 3.04M | 10.55% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 1.96M | 6.81% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 1.19M | 4.12% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 797.15K | 2.77% |
| iShares Trust-iShares Russell 2000 ETF | 699.62K | 2.43% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 304.05K | 1.05% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 293.10K | 1.02% |
| Vanguard Explorer Fund | 285.66K | 0.99% |
| iShares Trust-iShares Russell 2000 Value ETF | 255.26K | 0.89% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Small-Cap Equity Fund | 253.76K | 0.88% |
Frequently asked questions
Who is the largest shareholder of Arcturus Therapeutics?
ARK Investment Management, LLC is the largest institutional shareholder of ARCT, owning 10.39% of shares outstanding (2.99M shares) as of its latest 13F filing.
What percentage of Arcturus Therapeutics is owned by institutions?
Institutions own about 76.8% of ARCT shares and 84.9% of the public float.
How much of Arcturus Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.57% of ARCT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.